US Codex
Bill
Notes

Title II — Research on Cancer Symptom Management Improvement

H.R. 1661 · 113th Congress · Apr 19, 2013 · Lineage

II Research on Cancer Symptom Management Improvement

Sec. 201 Sense of Congress

It is the sense of Congress that—
(1)
many people with cancer experience side effects, symptoms, and late side effects associated with their disease and their treatment, and such effects can have a serious adverse impact on the effectiveness of their treatment, their health, well-being, and quality of life;
(2)
with the number of cancer survivors continuing to grow, addressing the effects of their symptoms and side effects is becoming increasingly critical in reducing the burden of cancer and its treatments;
(3)
although research is producing new insights into the causes of and cures for cancer, efforts to manage the symptoms and side effects of the disease and its treatments have not kept pace; and
(4)
the National Institutes of Health should continue to support research in the area of symptom management and the role that nurses play in providing those interventions.

Sec. 202 NIH Research on cancer symptom management improvement

(a)
In general— The Director of the National Institutes of Health shall expand, intensify, and coordinate programs for the conduct and support of research with respect to—
(1)
improving the treatment and management of symptoms and side effects associated with cancer and cancer treatment; and
(2)
evaluating the role of nursing interventions in the amelioration of such symptoms and side effects.
(b)
Administration— The Director of the National Institutes of Health is encouraged to carry out this section through the Director of the National Cancer Institute, in collaboration with at least the directors of the National Institute of Nursing Research, the National Institute of Neurological Disorders and Stroke, the National Institute of Mental Health, the National Center on Minority Health and Health Disparities, the National Center for Complementary and Alternative Medicine, and the Agency for Healthcare Research and Quality.